Found: 36
Select item for more details and to access through your institution.
Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0028-2
- By:
- Publication type:
- Article
Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0034-4
- By:
- Publication type:
- Article
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0027-3
- By:
- Publication type:
- Article
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0033-5
- By:
- Publication type:
- Article
Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0009-5
- By:
- Publication type:
- Article
Comprehensive definition of human immunodominant CD8 antigens in tuberculosis.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0008-6
- By:
- Publication type:
- Article
Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0007-7
- By:
- Publication type:
- Article
Protection of calves by a prefusion-stabilized bovine RSV F vaccine.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0005-9
- By:
- Publication type:
- Article
Escherichia coli-derived virus-like particles in vaccine development.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0006-8
- By:
- Publication type:
- Article
Inadvisable anti-vaccination sentiment: Human Papilloma Virus immunisation falsely under the microscope.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0004-x
- By:
- Publication type:
- Article
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0036-2
- By:
- Publication type:
- Article
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0038-0
- By:
- Publication type:
- Article
Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0035-3
- By:
- Publication type:
- Article
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0030-8
- By:
- Publication type:
- Article
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0029-1
- By:
- Publication type:
- Article
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0032-6
- By:
- Publication type:
- Article
Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0031-7
- By:
- Publication type:
- Article
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0026-4
- By:
- Publication type:
- Article
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0025-5
- By:
- Publication type:
- Article
Protein nanovaccine confers robust immunity against Toxoplasma.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0024-6
- By:
- Publication type:
- Article
H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0017-5
- By:
- Publication type:
- Article
A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0023-7
- By:
- Publication type:
- Article
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0016-6
- By:
- Publication type:
- Article
Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0021-9
- By:
- Publication type:
- Article
Antibody therapies for the prevention and treatment of viral infections.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0019-3
- By:
- Publication type:
- Article
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0018-4
- By:
- Publication type:
- Article
Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0022-8
- By:
- Publication type:
- Article
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0015-7
- By:
- Publication type:
- Article
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0020-x
- By:
- Publication type:
- Article
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0013-9
- By:
- Publication type:
- Article
Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0012-x
- By:
- Publication type:
- Article
Robust antibody and CD8<sup>+</sup> T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0011-y
- By:
- Publication type:
- Article
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0010-z
- By:
- Publication type:
- Article
Therapeutic vaccines for allergic disease.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0014-8
- By:
- Publication type:
- Article
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-016-0003-3
- By:
- Publication type:
- Article
Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-016-0001-5
- By:
- Publication type:
- Article